Results 41 to 50 of about 697,296 (219)

Antineutrophil Cytoplasmic Antibody-associated Vasculitis Management 2020: Where Are We Now?

open access: yes, 2021
The management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) has come a long way from the first postmortem descriptions of the diseases in the 1930s and 1950s1 Pivotal phases have been the introduction of glucocorticoids (GC ...

core   +2 more sources

Comparison Between cANCA and pANCA In Patients with Renal Disease

open access: yesDiyala Journal of Medicine, 2018
Background: Renal involvement is immensely include in antineutrophil cytoplasmic autoantibody (ANCA)-associated systemic vasculitis .It is a significant cause of end-stage renal failure.
Hiba Abid Al-Hussein Hassan   +3 more
doaj   +2 more sources

Effective Performance of the 2022 American College of Rheumatology/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in Pediatric Patients: An ARChiVe Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective To assess the 2022 American College of Rheumatology (ACR)/EULAR classification criteria for antineutrophil cytoplasmic antibody–associated vasculitis (AAV) in children with chronic small‐to‐medium vessel vasculitis. Methods A cohort of 574 patients, identified by physician's diagnosis (MD‐diagnosis) in A Registry of Childhood Vasculitis, was ...
David A. Cabral   +41 more
wiley   +1 more source

Infective endocarditis mimicking antineutrophil-cytoplasmic-antibody-associated vasculitis with glomerulonephritis: a case report

open access: yesJournal of Medical Case Reports
Background Infective endocarditis occasionally presents with antineutrophil cytoplasmic antibody positivity, leading to diagnostic challenges and confusion, as it can be mislabeled antineutrophil-cytoplasmic-antibody-associated vasculitis. Distinguishing
Ahmad Matarneh   +8 more
doaj   +1 more source

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis

open access: yesBMC Rheumatology, 2019
Background Anti-neutrophil cytoplasmic antibodies associated vasculitides (AAV) are characterized by autoimmune small vessel inflammation. Eosinophils are multifunctional cells with both pro-inflammatory and immunoregulatory properties.
Thomas Hellmark   +4 more
doaj   +1 more source

Higher Complement C4 Gene Copy Number Constitutes a Shared Genetic Risk Factor for Giant Cell Arteritis and IgA Vasculitis

open access: yesArthritis &Rheumatology, EarlyView.
Objective Low copy number (CN) of complement C4 isoforms and high CN of retroviral HERV‐K elements are known risk factors for many immune‐mediated inflammatory diseases (IMIDs), often showing sex‐biased effects. Here, we assessed whether CN variation within the C4 gene contributes to giant cell arteritis (GCA) and IgA vasculitis (IgAV), two complex ...
Laura Martínez‐Gutiérrez   +295 more
wiley   +1 more source

Development and initial evaluation of a measure of self-management for adults with antineutrophil cytoplasmic antibody-associated small-vessel vasculitis [PDF]

open access: yes, 2007
To develop a measure of illness self-management for adults living with antineutrophil cytoplasmic antibody (ANCA)–associated small-vessel vasculitis (ANCA-SVV) and to gather evidence of its reliability and ...
Thorpe, Carolyn T.   +5 more
core   +1 more source

Hydralazine-Induced ANCA Vasculitis With Overlapping Features of Lupus Erythematosus

open access: yesAnnals of Internal Medicine: Clinical Cases
Hydralazine is associated with drug-induced lupus erythematosus (DILE) and antineutrophil cytoplasmic antibody–associated vasculitis (AAV). A 72-year-old woman receiving hydralazine presented with acute kidney injury and positive antinuclear antibody ...
Andrea Ramirez Olarte   +4 more
doaj   +1 more source

Outcomes in Progressive Pulmonary Fibrosis in Systemic Autoimmune Rheumatic Diseases: Real‐World Data From the ILD‐PRO Registry

open access: yesArthritis &Rheumatology, EarlyView.
Objective We evaluated baseline characteristics, treatment patterns, and outcomes in patients with systemic autoimmune rheumatic disease–associated progressive pulmonary fibrosis (SARD‐PPF) and evaluated whether outcomes differed by SARD subtype. Methods The ILD‐PRO Registry is a prospective multicenter US registry of patients with PPF.
Sonali J. Bracken   +7 more
wiley   +1 more source

The Utility of serological markers in inflammatory bowel diseases: Gadget or magic? [PDF]

open access: yes, 2008
The panel of serologic markers for inflammatory bowel diseases (IBD) is rapidly expanding. Anti–Saccharomyces cerevisiae antibodies (ASCA) and atypical perinuclear antineutrophil cytoplasmic antibodies (P-ANCA) remain the most widely investigated ...
Papp, Mária   +3 more
core  

Home - About - Disclaimer - Privacy